COIOSDeep risk insights through multi-disciplinary research across the globe
people gathering in front of brown and white concrete building during daytime
Item refines Peer-reviewed Added

Lower systolic target in type 2 diabetes did not cut dementia or mild cognitive impairment

A systolic target below 120 mm Hg did not reduce dementia or mild cognitive impairment in type 2 diabetes.

This cognitive ancillary study of a randomised trial covered 12 434 adults in China with type 2 diabetes. Participants were aged 50 or over and randomised to a systolic target below 120 or 140 mm Hg. Over a median 3.8 years, dementia or mild cognitive impairment occurred in 747 intensive and 783 standard participants. Rates were 3.69 and 3.89 per 100 person years, a hazard ratio of 0.96 (95% CI 0.86 to 1.06). In an MRI subset of 862, white matter lesion volume grew less with intensive treatment. The trial was open label, and only 605 participants had end-of-study MRI.

Why it is interesting: The trial tests whether a lower systolic target protects cognition in people with type 2 diabetes. Lesion growth on MRI slowed, but diagnosed dementia or mild cognitive impairment did not change over a median 3.8 years.

Source
BMJ, 12 November 2026
Type
Peer-reviewed article
Design
Prespecified secondary-outcome analysis of a multicentre open-label RCT, 145 centres in China, 12 434 adults aged 50+ with type 2 diabetes, median 3.8 years follow-up, MRI substudy n=862
Verdict
Refines prior evidence
Driver
Obesity, diabetes and GLP-1
Driver
Dementia

Other drivers in Health today